STOCK TITAN

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

HeartBeam (NASDAQ: BEAT) has announced its upcoming Q3 2024 earnings conference call scheduled for November 7, 2024, at 4:30 p.m. Eastern time. The call will feature CEO Robert Eno, Founder and President Branislav Vajdic, and CFO Timothy Cruickshank discussing third quarter results, regulatory updates, ongoing initiatives, and anticipated milestones. A press release with detailed results will be issued before the call. The presentation will be accessible via webcast and the company's investor relations website. A replay will be available until February 7, 2025.

HeartBeam (NASDAQ: BEAT) ha annunciato la sua prossima conferenza telefonica sugli utili del terzo trimestre 2024, programmata per il 7 novembre 2024, alle 16:30, ora orientale. Durante la chiamata parteciperanno il CEO Robert Eno, il Fondatore e Presidente Branislav Vajdic e il CFO Timothy Cruickshank, i quali discuteranno i risultati del terzo trimestre, aggiornamenti normativi, iniziative in corso e traguardi attesi. Un comunicato stampa con i risultati dettagliati sarà emesso prima della chiamata. La presentazione sarà accessibile tramite webcast e sul sito web delle relazioni con gli investitori dell'azienda. Una registrazione sarà disponibile fino al 7 febbraio 2025.

HeartBeam (NASDAQ: BEAT) ha anunciado su próxima conferencia de ganancias del tercer trimestre de 2024, programada para el 7 de noviembre de 2024, a las 4:30 p.m. hora del este. La llamada contará con la participación del CEO Robert Eno, el Fundador y Presidente Branislav Vajdic, y el CFO Timothy Cruickshank, quienes discutirán los resultados del tercer trimestre, actualizaciones regulatorias, iniciativas en curso y los hitos anticipados. Un comunicado de prensa con detalles de los resultados se emitirá antes de la llamada. La presentación estará disponible a través de una transmisión web y en el sitio web de relaciones con inversores de la compañía. Una repetición estará disponible hasta el 7 de febrero de 2025.

HeartBeam (NASDAQ: BEAT)는 2024년 3분기 실적 컨퍼런스 콜이 2024년 11월 7일 동부시간 기준 오후 4시 30분에 예정되어 있다고 발표했습니다. 이번 콜에는 CEO 로버트 이노, 창립자 겸 회장 브라니스라프 바이디치, CFO 팀 크릭샹크가 참석해 3분기 결과, 규제 업데이트, 진행 중인 이니셔티브 및 예상되는 이정표에 대해 논의할 예정입니다. 콜 전 상세 결과가 담긴 보도자료가 발표될 것입니다. 발표는 웹캐스트 및 회사의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 재방송은 2025년 2월 7일까지 제공될 예정입니다.

HeartBeam (NASDAQ: BEAT) a annoncé sa prochaine conférence téléphonique sur les résultats du troisième trimestre 2024, prévue pour le 7 novembre 2024 à 16h30, heure de l'Est. L'appel mettra en avant le CEO Robert Eno, le Fondateur et Président Branislav Vajdic, ainsi que le CFO Timothy Cruickshank, qui discuteront des résultats du troisième trimestre, des mises à jour réglementaires, des initiatives en cours et des jalons attendus. Un communiqué de presse avec les résultats détaillés sera diffusé avant l'appel. La présentation sera accessible via un webcast et sur le site Internet des relations investisseurs de l'entreprise. Un enregistrement sera disponible jusqu'au 7 février 2025.

HeartBeam (NASDAQ: BEAT) hat seine bevorstehende Telefonkonferenz zu den Ergebnissen des dritten Quartals 2024 für den 7. November 2024 um 16:30 Uhr Eastern Time angekündigt. An dem Gespräch werden CEO Robert Eno, Gründer und Präsident Branislav Vajdic sowie CFO Timothy Cruickshank teilnehmen, um die Ergebnisse des dritten Quartals, regulatorische Updates, laufende Initiativen und erwartete Meilensteine zu besprechen. Eine Pressemitteilung mit detaillierten Ergebnissen wird vor der Konferenz veröffentlicht. Die Präsentation wird über ein Webcast und die Investor-Relations-Website des Unternehmens zugänglich sein. Eine Wiederholung wird bis zum 7. Februar 2025 verfügbar sein.

Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, will hold a conference call on Thursday, November 7, 2024 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2024, and will be providing regulatory updates, reviewing ongoing initiatives, and anticipated milestones. A press release detailing these results will be issued prior to the call.

HeartBeam CEO Robert Eno, Founder and President Branislav Vajdic, PhD, and CFO Timothy Cruickshank will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

To access the call, please use the following information:

Date:

     

Thursday, November 7, 2024

Time:

     

4:30 p.m. Eastern time (1:30 p.m. Pacific time)

Dial-in:

     

1-800-717-1738

International Dial-in:

     

1-646-307-1865

Conference Code:

     

1101650

Webcast:

     

https://viavid.webcasts.com/starthere.jsp?ei=1692718&tp_key=af2e025952

A telephone replay will be available approximately three hours after the call and will run through February 7, 2025, by dialing 1-844-512-2921 from the U.S., or 1-412-317-6671 from international locations, and entering replay pin number: 1101650. The replay can also be viewed through the webcast link above and the presentation utilized during the call will be available in the company’s investor relations section here.

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. The Company holds 13 US and 4 international issued patents related to technology enablement.

For additional information, visit HeartBeam.com.

Forward-Looking Statements

All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations Contact:

Chris Tyson

Executive Vice President

MZ North America

Direct: 949-491-8235

BEAT@mzgroup.us

www.mzgroup.us

Media Contact:

media@heartbeam.com

Source: HeartBeam, Inc.

FAQ

When is HeartBeam (BEAT) releasing Q3 2024 earnings?

HeartBeam (BEAT) will release Q3 2024 earnings on Thursday, November 7, 2024, with a conference call scheduled for 4:30 p.m. Eastern time.

How can investors access HeartBeam's (BEAT) Q3 2024 earnings call?

Investors can access the call by dialing 1-800-717-1738 (US) or 1-646-307-1865 (International) with conference code 1101650, or via webcast at the company's investor relations website.

How long will HeartBeam's (BEAT) Q3 2024 earnings call replay be available?

The earnings call replay will be available until February 7, 2025, accessible by dialing 1-844-512-2921 (US) or 1-412-317-6671 (International) with pin number 1101650.

Heartbeam, Inc.

NASDAQ:BEAT

BEAT Rankings

BEAT Latest News

BEAT Stock Data

74.66M
18.98M
29.25%
8.73%
0.47%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States of America
SANTA CLARA